Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2173 Salk Avenue, Suite 200, Carlsbad, California
State of incorporation
California
Fiscal year end
December 31
Former names
BIOTIME INC (to 8/8/2019)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264 % -12.1%
Debt-to-equity 56.6 % -15.3%
Return On Equity -34.9 % -11.2%
Return On Assets -22.1 % -18.4%
Operating Margin -309 % -61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 189M shares +10.8%
Common Stock, Shares, Outstanding 189M shares +10.9%
Entity Public Float 186M USD -7.48%
Common Stock, Value, Issued 467M USD +5.73%
Weighted Average Number of Shares Outstanding, Basic 183M shares +7.51%
Weighted Average Number of Shares Outstanding, Diluted 183M shares +7.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8M USD -32.5%
Revenue from Contract with Customer, Excluding Assessed Tax 1.44M USD -39.5%
Cost of Revenue 650K USD -3.13%
Research and Development Expense 14.5M USD -4.31%
General and Administrative Expense 17.6M USD -6.33%
Costs and Expenses 8.11M USD -10.2%
Operating Income (Loss) -24.8M USD -8.72%
Nonoperating Income (Expense) 1.12M USD -76.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.6M USD +5.19%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -23.7M USD -0.42%
Earnings Per Share, Basic -0.14 USD/shares 0%
Earnings Per Share, Diluted -0.14 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.6M USD +182%
Marketable Securities, Current 45K USD -99.9%
Accounts Receivable, after Allowance for Credit Loss, Current 77K USD
Assets, Current 45.7M USD -7.93%
Property, Plant and Equipment, Net 2.1M USD -62.3%
Operating Lease, Right-of-Use Asset 2.86M USD
Intangible Assets, Net (Excluding Goodwill) 46.5M USD -0.26%
Goodwill 10.7M USD 0%
Assets 108M USD -4.17%
Accounts Payable, Current 2.21M USD -26.3%
Employee-related Liabilities, Current 2.48M USD +37.1%
Accrued Liabilities, Current 991K USD +145%
Contract with Customer, Liability, Current 10.1M USD -72.4%
Liabilities, Current 16.9M USD -1.95%
Contract with Customer, Liability, Noncurrent 21.2M USD
Deferred Income Tax Liabilities, Net 273K USD 0%
Operating Lease, Liability, Noncurrent 2.07M USD -18.4%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 37.5M USD -15.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.77M USD +10.8%
Retained Earnings (Accumulated Deficit) -391M USD -6.43%
Stockholders' Equity Attributable to Parent 72.4M USD +2.77%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 71M USD +2.86%
Liabilities and Equity 108M USD -4.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.78M USD +48.6%
Net Cash Provided by (Used in) Financing Activities 14M USD +1402000%
Net Cash Provided by (Used in) Investing Activities -38K USD -100%
Common Stock, Shares Authorized 450M shares +80%
Common Stock, Shares, Issued 189M shares +10.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.13M USD +99%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.1M USD +175%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD 0%
Deferred Tax Assets, Valuation Allowance 80.5M USD +2.95%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 85.2M USD +8.3%
Operating Lease, Liability 3.13M USD
Payments to Acquire Property, Plant, and Equipment 38K USD -79.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.3M USD -8.07%
Lessee, Operating Lease, Liability, to be Paid 2.38M USD
Operating Lease, Liability, Current 1.05M USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 508K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 531K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 330K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 486K USD
Deferred Tax Assets, Operating Loss Carryforwards 63.5M USD +7.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.96M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 407K USD
Operating Lease, Payments 302K USD -4.13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 22K USD -33.3%
Depreciation, Depletion and Amortization 138K USD -8%
Deferred Tax Assets, Net of Valuation Allowance 4.73M USD +847%
Share-based Payment Arrangement, Expense 1.16M USD +12.8%